Akers Biosciences Inc. | Balance Sheet
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
103.60
9,720.80
4,427.20
122.70
5,450.00
5,454.80
Total Accounts Receivable
2,076.80
2,326.20
736.30
633.20
964.70
176.30
Inventories
1,025.10
905.10
1,131.70
2,036.50
947.60
585.30
Other Current Assets
163.90
107.60
186.00
394.60
413.60
453.80
Total Current Assets
3,369.40
13,059.70
6,481.10
3,186.90
7,775.90
6,670.10
Net Property, Plant & Equipment
267.30
201.50
251.10
259.40
235.10
83.50
Total Investments and Advances
-
-
64.10
-
-
500
Long-Term Note Receivable
-
1,209.30
-
-
-
-
Intangible Assets
2,434.60
2,176.10
1,472.90
1,301.80
1,130.70
243.40
Other Assets
4.30
4.30
2.70
337.00
196.20
310.30
Total Assets
6,075.60
16,650.90
8,271.90
5,085.10
9,337.90
7,807.30
ST Debt & Current Portion LT Debt
307.50
-
-
-
-
Accounts Payable
623.20
364.10
538.40
1,105.30
988.80
Other Current Liabilities
1,022.70
1,479.90
1,130.30
592.10
796.30
Total Current Liabilities
1,953.40
1,844.00
1,668.70
1,697.40
1,785.00
Total Liabilities
1,953.40
1,844.00
1,668.70
1,697.40
1,785.00
Common Equity (Total)
4,122.20
14,806.90
6,603.20
3,387.70
5,797.90
Total Shareholders' Equity
4,122.20
14,806.90
6,603.20
3,387.70
7,552.90
Total Equity
4,122.20
14,806.90
6,603.20
3,387.70
7,552.90
Liabilities & Shareholders' Equity
6,075.60
16,650.90
8,271.90
5,085.10
9,337.90
Preferred Stock (Carrying Value)
-
-
-
-
1,755.00
About Akers Biosciences
View Profile
